Signs MOA With IIT Kanpur For Novel Gene Therapy Assets
19/06/2023 07:23
June 19 (Reuters) - Laurus Labs Ltd LAUL.NS :
* LAURUS LABS LTD- SIGNS MEMORANDUM OF AGREEMENT WITH IIT
KANPUR
FOR NOVEL GENE THERAPY ASSETS
* LAURUS LABS LTD- WILL IN- LICENSE FEW GENE THERAPY ASSETS
* LAURUS LABS LTD- WILL ALSO PROVIDE FUNDING FOR CLINICAL
TRIALS
AND WILL LAUNCH THESE PRODUCTS IN INDIA AND EMERGING MARKETS
Source text for Eikon: ID:nBSE9Fm0mP
Further company coverage: LAUL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Laurus Labs
See all newsIndia's Laurus Labs hits record high as Q2 profit more than doubles
Brief: Laurus Labs Declares Dividend Of 1 Rupee Per Share
Brief: Laurus Labs Invests 1.08 Billion Rupees Into KRKA Pharma Via Rights Issue
Brief: Laurus Labs Invests 120.96 Million Rupees In Kurnool Renewables Via Rights Issue
Four Indian stocks to be added, three removed from key global index in MSCI's August rejig